Among patients with prostate cancer, a high omega-3, low-omega-6 diet with fish oil led to a Ki-67 index decrease.

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...

In the next in our series, GP Dr Roger Henderson debunks common myths about prostate cancer – and highlights some less ...

The 18-gene MyProstateScore 2.0 (MPS2) test using first-catch non-digital rectal examination (DRE) urine is highly se ...

Prostatitis is treated with antibiotics and anti-inflammatory agents. BPH is treated with one or more medications to reduce ...

PORTOS can determine which patients with localized prostate cancer will benefit from dose-escalation of radiotherapy, data suggest.

As you navigate the challenges of prostate cancer and erectile dysfunction, remember that you are not alone. With advances in ...

Despite guidelines addressing overdetection, no significant declines are seen; emphasis on active surveillance approaches is ...

The new vaccine is "personalized," meaning it is designed to train the patient's immune system to recognize and eliminate any remaining cells of that person's cancer.

Dr. Bansal and Staff Sandeep Bansal, MD, FCCP, FACP, Medical Director of The Lung Center and Interventional Pulmonology at ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, and Tempus, a technology company leading the adoption of AI to advance precision ...